IFCAH Research Grant

The International Fund Congenital Adrenal Hyperplasia (IFCAH), in partnership with the European Society for Paediatric Endocrinology (ESPE) and the European Society of Endocrinology (ESE), offers research grants to support academic research on Congenital Adrenal Hyperplasia (CAH). Created in 2010 by parents of children affected by CAH, IFCAH aims to give strong support to research dedicated to improving patients' quality of life. The program focuses on three specific goals: proposition of new therapeutic targets and protocols including pharmacotherapy, development of gene or cellular therapy models, and improvement of current treatment monitoring; increasing knowledge on pathophysiology of CAH including research on adrenal development, differentiation and homeostasis; and prevention, diagnostic and treatment of natural or iatrogenic complications affecting foetal development, growth, puberty, metabolic and cardiovascular systems, fertility, bone density, immunity, infection, and neurocognition. Selected research projects will be supported up to EUR 150,000 total over a funding period not exceeding three years. The total program budget is €350,000. Funds can be used for expenses directly linked to the project, including specific equipment, operating costs, or salaries of coworkers (excluding salaries of senior permanent staff). Indirect costs or management fees are not eligible. The funding is open to co-funding opportunities to support larger projects.